In our study, the expression of LC3II and P62 was increased, whereas the expression of beclin 1, LAMP2, and cathepsin D was inhibited in the myocardium during diabetic cardiomyopathy and in PA-induced NMCMs. Here, LAMP2 is linked to diabetic cardiomyopathy.